Korea S.E.
06:00:00 2024-06-04 pm EDT
5-day change
1st Jan Change
2,610
KRW
+1.16%
-2.79%
-15.53%
KNOTUS Co.,Ltd has filed an IPO.
June 04, 2019 at 12:00 am EDT
KNOTUS Co.,Ltd has filed an IPO.
Security Name: Shares
Security Type: Common Stock
PriceRange: KRW 15100 to KRW 17300
Transaction Features: ESOP Related Offering; Sponsor Backed Offering
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
May. 20
CI
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.
May. 19
CI
Tranche Update on HLB bioStep Co.,Ltd.'s Equity Buyback Plan announced on February 8, 2024.
May. 17
CI
HLB bioStep Co.,Ltd. announced that it has received KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd.
May. 08
CI
HLB bioStep Co.,Ltd. announced that it expects to receive KRW 1.438165744 billion in funding from Kangstem Biotech Co., Ltd.
Apr. 24
CI
Tranche Update on HLB bioStep Co.,Ltd.'s Equity Buyback Plan announced on December 4, 2023.
Mar. 08
CI
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.
Feb. 08
CI
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.
Feb. 07
CI
HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
Dec. 04
CI
HLB bioStep Co.,Ltd. authorizes a Buyback Plan.
Dec. 03
CI
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors
23-06-20
CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.
23-06-20
CI
HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors
23-03-12
CI
HLB SCIENCE Inc. announced that it has received KRW 5.0000004 billion in funding from HLB bioStep Co.,Ltd.
23-02-08
CI
HLB SCIENCE Inc. announced that it expects to receive KRW 5.0000004 billion in funding from HLB bioStep Co.,Ltd.
23-01-31
CI
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors
23-01-31
CI
KNOTUS Co.,Ltd's Equity Buyback announced on March 13, 2020 has expired with 71,714 shares, representing 0.98% for KRW 960.15 million.
22-03-11
CI
KNOTUS Co.,Ltd announced that it has received KRW 81.1 billion in funding
22-01-12
CI
HLB Co., Ltd. entered into a contract to acquire 18.4% stake in KNOTUS Co.,Ltd from Jeong In-seong and Kim Do-hyung for KRW 56.2 billion.
21-12-26
CI
KNOTUS Co.,Ltd announced that it expects to receive KRW 94.6 billion in funding
21-12-26
CI
KNOTUS Co.,Ltd(KOSDAQ:A278650) added to S&P Global BMI Index
21-09-20
CI
Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.
21-06-14
CI
Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.
21-06-14
CI
KNOTUS Co.,Ltd's Equity Buyback Plan Extended till March 12, 2022.
21-03-11
CI
Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.
20-12-13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
HLB bioStep Co Ltd, formerly KNOTUS Co Ltd, is a Korea-based company mainly engaged in non-clinical trial business. The Company operates through three segments. The Non-clinical Test Consignment Agency Business segment conducts non-clinical is mainly engaged in the test on newly developed substances such as new drugs ,and tests the efficacy and pharmacodynamics of substances. In addition, this segment is engaged in the test of the safety of substances. The Bioinfra Business segment is engaged in animal laboratory design, construction, and maintenance. In addition, this segment provides equipment delivery. The Pet Medical Business segment is engaged in the development of veterinary medicine and the sale of companion animal products.
More about the company
1st Jan change
Capi.
-15.53% 161M +10.91% 3.43B +3.32% 2.27B -19.52% 2.03B -20.21% 1.63B +32.90% 1.16B +15.83% 714M -9.39% 703M -22.96% 500M -1.29% 279M
Bio Diagnostics & Testing
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
HLB BIOSTEP CO.,LTD. 
